769 related articles for article (PubMed ID: 26663802)
21. The clinical aspects of biclonal gammopathies. Review of 57 cases.
Kyle RA; Robinson RA; Katzmann JA
Am J Med; 1981 Dec; 71(6):999-1008. PubMed ID: 6797297
[TBL] [Abstract][Full Text] [Related]
22. IgM demyelinative neuropathy with amyloidosis and biclonal gammopathy.
Julien J; Vital C; Vallat JM; Lagueny A; Ferrer X; Deminiere C; Leboutet MJ; Effroy C
Ann Neurol; 1984 Apr; 15(4):395-9. PubMed ID: 6430211
[TBL] [Abstract][Full Text] [Related]
23. Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays.
Katzmann JA; Dispenzieri A; Kyle RA; Snyder MR; Plevak MF; Larson DR; Abraham RS; Lust JA; Melton LJ; Rajkumar SV
Mayo Clin Proc; 2006 Dec; 81(12):1575-8. PubMed ID: 17165636
[TBL] [Abstract][Full Text] [Related]
24. Biclonal gammopathy (IgG kappa and IgG lambda) in a patient with non-Hodgkin's lymphoma.
Guarner J; Austin GE; Nassar VH; Sarma PR; Boedecker E
Arch Pathol Lab Med; 1986 May; 110(5):445-8. PubMed ID: 3083801
[TBL] [Abstract][Full Text] [Related]
25. POEMS Syndrome with Biclonal Gammopathy and Renal Involvement.
Inoue K; Nagai K; Tsukada T; Iwase M; Sakata A; Ueda A; Yamagata K
Intern Med; 2022 Jul; 61(14):2191-2196. PubMed ID: 35283379
[TBL] [Abstract][Full Text] [Related]
26. Poems syndrome.
Leung NW; Lam CW; Pang JC
Pathology; 1991 Apr; 23(2):167-71. PubMed ID: 1745570
[TBL] [Abstract][Full Text] [Related]
27. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
[TBL] [Abstract][Full Text] [Related]
28. Plasma-cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome.
Miralles GD; O'Fallon JR; Talley NJ
N Engl J Med; 1992 Dec; 327(27):1919-23. PubMed ID: 1333569
[TBL] [Abstract][Full Text] [Related]
29. Relationship of differences in immunoglobulin heavy/light chain pairs (Hevylite), selected laboratory parameters and stratification systems in different immunochemical types of multiple myeloma.
Scudla V; Lochman P; Pika T; Minarik J; Zapletalova J; Bacovsky J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):84-93. PubMed ID: 26365929
[TBL] [Abstract][Full Text] [Related]
30. Assessing the efficiency of free light chain assay in monitoring patients with multiple myeloma before and after autologous stem cell transplantation along with serum protein electrophoresis and serum protein immunofixation.
Dogaru M; Lazăr V; Coriu D
Roum Arch Microbiol Immunol; 2011; 70(1):15-22. PubMed ID: 21717807
[TBL] [Abstract][Full Text] [Related]
31. [Biclonal light chain gammopathy in multiple myeloma--a case report].
Ogasawara T; Yasuyama M; Kawauchi K
Nihon Rinsho Meneki Gakkai Kaishi; 2002 Apr; 25(2):170-6. PubMed ID: 12043184
[TBL] [Abstract][Full Text] [Related]
32. Serum free light chains in clinical laboratory diagnostics.
Jenner E
Clin Chim Acta; 2014 Jan; 427():15-20. PubMed ID: 23999048
[TBL] [Abstract][Full Text] [Related]
33. Assessment of the analytical performance and the sensitivity of serum free light chains immunoassay in patients with monoclonal gammopathy.
Wolff F; Thiry C; Willems D
Clin Biochem; 2007 Mar; 40(5-6):351-4. PubMed ID: 17239359
[TBL] [Abstract][Full Text] [Related]
34. Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance.
Rajkumar SV; Kyle RA; Therneau TM; Clark RJ; Bradwell AR; Melton LJ; Larson DR; Plevak MF; Katzmann JA
Br J Haematol; 2004 Nov; 127(3):308-10. PubMed ID: 15491291
[TBL] [Abstract][Full Text] [Related]
35. Biclonal IgA and IgM gammopathy in lymphocytic lymphoma.
Weinstein S; Jain A; Bhagavan NV; Scottolini AG
Clin Chem; 1984 Oct; 30(10):1710-2. PubMed ID: 6434203
[TBL] [Abstract][Full Text] [Related]
36. Polyneuropathy, organomegaly, endocrinopathy, M-protein and skin change (POEMS) syndrome with IgG kappa paraproteinemia.
Romas E; Storey E; Ayers M; Byrne E
Pathology; 1992 Jul; 24(3):217-20. PubMed ID: 1437299
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of the new Hevylite™ IgA assay for the diagnosis and follow-up of monoclonal gammopathies].
Lakomy D; Lemaire-Ewing S; Denimal D; Bastie JN; Lafon I; Caillot D
Ann Biol Clin (Paris); 2013; 71(2):157-63. PubMed ID: 23587579
[TBL] [Abstract][Full Text] [Related]
38. Quantification of Free Immunoglobulin Light Chains in Urine.
Singh G; Cotter T; Ye Mon M; Xu H; Bollag RJ
J Appl Lab Med; 2023 Nov; 8(6):1101-1114. PubMed ID: 37725944
[TBL] [Abstract][Full Text] [Related]
39. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M
Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439
[TBL] [Abstract][Full Text] [Related]
40. [Incidence and type of monoclonal or biclonal gammopathies in scrub typhus].
Cho JH; Park DS
Korean J Lab Med; 2009 Apr; 29(2):116-21. PubMed ID: 19411777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
